Symptom Onset Antidepressant Treatment for PMDD.
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Sertraline (Primary)
- Indications Premenstrual dysphoric disorder
- Focus Therapeutic Use
- 27 Jun 2012 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 27 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Oct 2007 New trial record.